Want to see DE:MED full AI Analyst Report?

MEDICLIN (MED) Price & Analysis

1 Followers

MED Stock Chart & Stats

€3.60

-€0.06(-2.44%)

At close: Jan 08 4:00 PM EST

€3.60

-€0.06(-2.44%)

Day’s Range― - ―

52-Week Range€2.86 - €4.26

Previous CloseN/A

Volume500.00

Average Volume (3M)5.25K

Market Cap

€188.10M

Enterprise Value€483.17M

Total Cash (Recent Filing)€152.40M

Total Debt (Recent Filing)€369.54M

Price to Earnings (P/E)6.6

Beta0.22

Next Earnings

Jul 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.12%

Share Statistics

EPS (TTM)0.60

Shares Outstanding47,500,000

10 Day Avg. Volume4,347

30 Day Avg. Volume5,253

Financial Highlights & Ratios

PEG Ratio1.78

Price to Book (P/B)0.71

Price to Sales (P/S)0.22

P/FCF Ratio3.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.78

Revenue Forecast (FY)€805.60M

Bulls Say, Bears Say

Bulls Say

Diversified Care NetworkMEDICLIN’s integrated network of acute, rehab and outpatient sites creates diversified revenue streams tied to durable demand for clinical care. This mix reduces single-service exposure, supports steady patient volumes and creates cross-referral and utilization advantages over 2–6 months.

Improving Operating PerformanceA 26% TTM revenue increase plus returned profitability indicates recovering utilization and better cost absorption. Sustained top-line growth and restored EBIT/net margins support ongoing cash generation and operational resilience if trends persist over the medium term.

Healthy Cash GenerationStrong operating cash flow and positive FCF provide recurring internal funding for capex, dividends and debt service. Even with modest conversion, consistent cash generation improves financial flexibility and underpins the company’s ability to delever and invest over several quarters.

Bears Say

Elevated LeverageRemaining debt-heavy capital structure limits balance-sheet flexibility and raises sensitivity to earnings shocks or higher funding costs. Even with improvement, leverage near 1.5x constrains capacity for acquisitions or meaningful capital returns without further deleveraging.

Thin, Volatile MarginsLow and inconsistent margins reduce the company’s ability to absorb reimbursement shifts or rising input costs. Historical swings, including a full-year loss, imply operational sensitivity and make forward earnings predictability and sustained margin expansion uncertain.

Negative Free Cash Flow GrowthDeclining FCF growth and only moderate conversion of earnings to cash slow deleveraging and limit reinvestment capacity. If FCF fails to recover, management may face trade-offs between capex, dividends and accelerating debt reduction.

MED FAQ

What was MEDICLIN AG’s price range in the past 12 months?

MEDICLIN AG lowest stock price was €2.86 and its highest was €4.26 in the past 12 months.

What is MEDICLIN AG’s market cap?

MEDICLIN AG’s market cap is €188.10M.

When is MEDICLIN AG’s upcoming earnings report date?

MEDICLIN AG’s upcoming earnings report date is Jul 30, 2026 which is in 29 days.

How were MEDICLIN AG’s earnings last quarter?

MEDICLIN AG released its earnings results on May 04, 2026. The company reported €0.074 earnings per share for the quarter, beating the consensus estimate of N/A by €0.074.

Is MEDICLIN AG overvalued?

According to Wall Street analysts MEDICLIN AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MEDICLIN AG pay dividends?

MEDICLIN AG pays a Annually dividend of €0.04 which represents an annual dividend yield of 1.12%. See more information on MEDICLIN AG dividends here

What is MEDICLIN AG’s EPS estimate?

MEDICLIN AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MEDICLIN AG have?

MEDICLIN AG has 47,500,000 shares outstanding.

What happened to MEDICLIN AG’s price movement after its last earnings report?

MEDICLIN AG reported an EPS of €0.074 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.725%.

Which hedge fund is a major shareholder of MEDICLIN AG?

Currently, no hedge funds are holding shares in DE:MED

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MEDICLIN Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

11.90%

Trailing 12-Months

Asset Growth

-6.83%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

MEDICLIN AG

Mediclin AG is a German healthcare enterprise primarily engaged in managing hospitals across the nation. Its operations are categorized into three main segments: Post-Acute, Acute, and various other related activities. The company offers a comprehensive range of medical specializations, encompassing fields such as neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, and surgical interventions, in addition to general nursing care. Furthermore, Mediclin provides specialized services like ear, nose, and throat (ENT) treatment and acute outpatient care. As of December 31, 2021, its extensive network comprised 34 clinics, 7 nursing care facilities, and 11 medical care centres. This infrastructure collectively provided a significant capacity of 7,831 beds and 482 nursing places, distributed across eleven of Germany's federal states. The company's corporate headquarters are situated in Offenburg, Germany.